Rilotumumab Completed Phase 1 Trials for Part 2- Advanced or Metastatic Gastric Cancer / Part 1- Advanced Solid Tumors / Part 2- Advanced or Metastatic GEJ Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01791374Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ